esa- antitrombotic therapy
TRANSCRIPT
![Page 1: ESA- antitrombotic therapy](https://reader035.vdocuments.net/reader035/viewer/2022071815/55a96f011a28ab30508b4725/html5/thumbnails/1.jpg)
Recommendations of the European Society of Anesthesiology
Gogarten, Wiebke; Vandermeulen, Erik; Van Aken, Hugo; Kozek, Sibylle; Llau, Juan V; Samama, Charles MEuropean Journal of Anaesthesiology. 27(12):999-1015, December 2010.
Miljenko MratinovićTomislav Čutura
![Page 2: ESA- antitrombotic therapy](https://reader035.vdocuments.net/reader035/viewer/2022071815/55a96f011a28ab30508b4725/html5/thumbnails/2.jpg)
Spinal epidural haematoma in patients on antithrombotic drugsFirst national recommendations on neuraxial
anaesthesia and antithrombotic drugs1997. German Society for Anaesthesiology and Intensive
Care1998. ASRA2000. Belgian anaesthesiologists
Regional anaesthesia and antithrombotic agents
![Page 3: ESA- antitrombotic therapy](https://reader035.vdocuments.net/reader035/viewer/2022071815/55a96f011a28ab30508b4725/html5/thumbnails/3.jpg)
Recommendations are based on case report and expert opinion ( mainly on knowledge of the pharmacokinetics of individual agent)
Mostly the time interval between cessation of medication and neuraxial blocade at 2x the elimination half-life of the drug.
Regional anaesthesia and antithrombotic agents
![Page 4: ESA- antitrombotic therapy](https://reader035.vdocuments.net/reader035/viewer/2022071815/55a96f011a28ab30508b4725/html5/thumbnails/4.jpg)
The risk of haemorrhage ↓ spinal anaesthesia ↑epidural catether anaesthesia
½ of all cases of bleeding occur during the removal of an epidural catether
Regional anaesthesia and antithrombotic agents
![Page 5: ESA- antitrombotic therapy](https://reader035.vdocuments.net/reader035/viewer/2022071815/55a96f011a28ab30508b4725/html5/thumbnails/5.jpg)
Tromboprophylaxis preoperatively vs. postoperatively (exeption neurosurgery)
A meta-analysis of preoperative vs. postoperative studies shows that LMWH given 12 h preoperatively does not reduce the risk of VTE compared to postoperative regime
German guidelines on thromboprophylaxis refer to preoperative administration only as an option, not as a requirement.
Regional anaesthesia and antithrombotic agents
![Page 6: ESA- antitrombotic therapy](https://reader035.vdocuments.net/reader035/viewer/2022071815/55a96f011a28ab30508b4725/html5/thumbnails/6.jpg)
Because preoperative vs. postoperative thromboprophylaxis is not proven to be beneficial, in the presence of acetylsalicylic acid, VTE prophylaxis should be started postoperatively.
AHA recommends acetylsalicylic acid administration on a life-long basis and perioperative interruptions should be avoided in patients with DES/BMS.
Regional anaesthesia and antithrombotic agents
Tromboprophylaxis preoperatively vs. postoperatively (exeption neurosurgery)
![Page 7: ESA- antitrombotic therapy](https://reader035.vdocuments.net/reader035/viewer/2022071815/55a96f011a28ab30508b4725/html5/thumbnails/7.jpg)
Antithrombotic drugs
Heparins - UFH, LMWHAnti-Xa agents - fondaparinux, idrabiotaparinux,
rivaroxaban, apixaban, danaparoid Direct trombin inhibitors - desirudin, lepirudin,
hirudin, argatrobanVitamin K antagonists - warfarin, fluindione,
acenocoumarol, phenprocoumon
Regional anaesthesia and antithrombotic agents
![Page 8: ESA- antitrombotic therapy](https://reader035.vdocuments.net/reader035/viewer/2022071815/55a96f011a28ab30508b4725/html5/thumbnails/8.jpg)
Antithrombotic drugs
Platelet aggregation inhibitors - acetylsalicylic acid, thienopyridines, clopidogrel, selective serotonin reuptake inhibitors, glycoprotein IIb/IIIa inhibitors (abciximab, tirofibam, eptifibatide
Regional anaesthesia and antithrombotic agents
![Page 9: ESA- antitrombotic therapy](https://reader035.vdocuments.net/reader035/viewer/2022071815/55a96f011a28ab30508b4725/html5/thumbnails/9.jpg)
HeparinsBinds to the enzyme inhibitor antithrombin III (AT)UFH – 1/2 elimination 60 min.
4-6h between iv. administration and puncture or catether manipulation or withdrawal ( aPTT normalised)
further administration delayed for 1h ( ACT maintained at 2x the baseline value)
LMWH – 1/2 elimination 4-7h12h between sc. administration and neuraxial blockade or
removal of an epidural cateter ( plasma anti-factor Xa activity)
Regional anaesthesia and antithrombotic agents
![Page 10: ESA- antitrombotic therapy](https://reader035.vdocuments.net/reader035/viewer/2022071815/55a96f011a28ab30508b4725/html5/thumbnails/10.jpg)
Anti Xa agents inhibitors
Fondaparinux - alternative anticoagulant in HIT1/2 elimination 18h36h before catether removal, and 12h between the next dose
Idrabiotaparinux – 1/2 elimination 135h and up to 66 daysno data regarding neuraxial anesthesia
Rivaroxaban - 22-26h between the last dose and catether withdrawalnext dose may be given after 4-6h
Regional anaesthesia and antithrombotic agents
![Page 11: ESA- antitrombotic therapy](https://reader035.vdocuments.net/reader035/viewer/2022071815/55a96f011a28ab30508b4725/html5/thumbnails/11.jpg)
Direct trombin inhibitors
Desirudin, lepirudin - 8-10h between the administration and neuraxial punction
Argatroban - administered iv. in treatment of HIT eliminated exclusively by liver 1/2 elimination 35-45 min ( normalisation of aPTT takes 2-4h)
Regional anaesthesia and antithrombotic agents
![Page 12: ESA- antitrombotic therapy](https://reader035.vdocuments.net/reader035/viewer/2022071815/55a96f011a28ab30508b4725/html5/thumbnails/12.jpg)
Vitamin K antagonists
warfarin, fluindione, acenocoumarol, phenprocoumon
II, VII, IX, X coagulation factors normalisation of INR → INR<1,4 ( Vit.K, PCC,
FFP)
Regional anaesthesia and antithrombotic agents
![Page 13: ESA- antitrombotic therapy](https://reader035.vdocuments.net/reader035/viewer/2022071815/55a96f011a28ab30508b4725/html5/thumbnails/13.jpg)
Platelet aggregation inhibitors
Acetylsalicylic acid irreversible inhibition of cyclo-oxygenase when given in isolation do not increase the risk of spinal epidural
haemathoma and are not a contraindication to neuraxial block
Thienopyridines - irreversible antagonosing ADP at the platelets purine receptors
Ticlopidine - neuraxial regional anesthesia should not be performed until 10 days elapsed between last ingestion and the procedure
Clopidrogel - 7 days after the last intake
Regional anaesthesia and antithrombotic agents
![Page 14: ESA- antitrombotic therapy](https://reader035.vdocuments.net/reader035/viewer/2022071815/55a96f011a28ab30508b4725/html5/thumbnails/14.jpg)
Glycoprotein IIa/IIIb inhibitors - abciximab, tirofibam, eptifibatide the most potent form of platelet inhibition reduces thrombin generationare used only in ACS ( in combination with anticoagulants and
aspirin )cardiac surgery procedures are emergencies with continuing
antigoagulation → neuraxial blockade is contrainicated!
Regional anaesthesia and antithrombotic agents
![Page 15: ESA- antitrombotic therapy](https://reader035.vdocuments.net/reader035/viewer/2022071815/55a96f011a28ab30508b4725/html5/thumbnails/15.jpg)
Platelet aggregation inhibitors
If a catheter has to be removed after administration of glycoprotein inhibitors, most guidelines recomend waiting at least 48h after abciximab, and 8-10 h after tirofiban or eptifibatide ( platelet count should be obtained to exclude thrombocytopenia )
Regional anaesthesia and antithrombotic agents
![Page 16: ESA- antitrombotic therapy](https://reader035.vdocuments.net/reader035/viewer/2022071815/55a96f011a28ab30508b4725/html5/thumbnails/16.jpg)
HVALA!
Regional anaesthesia and antithrombotic agents